Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study
- PMID: 27190081
- PMCID: PMC5374723
- DOI: 10.1177/1479164116629353
Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study
Abstract
Background: The formal identification of subgroups with varying levels of risk is uncommon in observational studies of cardiovascular disease, although such insight might be useful for clinical management.
Methods: Tree-structured survival analysis was utilized to determine whether there are meaningful subgroups at varying levels of cardiovascular disease risk in the Pittsburgh Epidemiology of Diabetes Complications study, a prospective cohort study of childhood-onset (<17 years old) type 1 diabetes.
Results: Of the 561 participants free of cardiovascular disease (coronary artery disease, stroke or lower extremity arterial disease) at baseline, 263 (46.9%) had an incident cardiovascular disease event over the 25-year follow-up. Tree-structured survival analysis revealed a range of risk groups, from 24% to 85%, which demonstrate that those with short diabetes duration and elevated non-high-density lipoprotein cholesterol have similar cardiovascular disease risk to those with long diabetes duration and that renal disease is a better discriminator of risk in men than in women.
Conclusion: Our findings suggest that subgroups with major cardiovascular disease risk differences exist in this type 1 diabetes cohort. Using tree-structured survival analysis may help to identify these groups and the interrelationships between their associated risk factors. This approach may improve our understanding of various clinical pathways to cardiovascular disease and help target intervention strategies.
Keywords: Decision trees; cardiovascular disease; risk stratification; type 1 diabetes.
© The Author(s) 2016.
Conflict of interest statement
CONFLICTS OF INTEREST:
Trevor J. Orchard provides consulting for Eli Lilly and Company and Profil Institute for Clinical Research. The other authors have no potential conflicts to declare.
Figures




Similar articles
-
A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study.Diabetes Care. 2016 Dec;39(12):2296-2303. doi: 10.2337/dc16-1162. Epub 2016 Sep 21. Diabetes Care. 2016. PMID: 27654986 Free PMC article.
-
[The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].Herz. 2004 Aug;29(5):463-9. doi: 10.1007/s00059-004-2606-0. Herz. 2004. PMID: 15340731 German.
-
Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study.Diabetes Care. 2013 Dec;36(12):3999-4006. doi: 10.2337/dc13-1142. Epub 2013 Oct 29. Diabetes Care. 2013. PMID: 24170748 Free PMC article.
-
Cardiovascular disease risk in young people with type 1 diabetes.J Cardiovasc Transl Res. 2012 Aug;5(4):446-62. doi: 10.1007/s12265-012-9363-x. Epub 2012 Apr 12. J Cardiovasc Transl Res. 2012. PMID: 22528676 Review.
-
Cardiovascular disease in diabetes type 2: current concepts.J Intern Med. 2018 Sep;284(3):240-253. doi: 10.1111/joim.12804. Epub 2018 Jul 18. J Intern Med. 2018. PMID: 29923339 Review.
Cited by
-
The Reporting Quality of Machine Learning Studies on Pediatric Diabetes Mellitus: Systematic Review.J Med Internet Res. 2024 Jan 19;26:e47430. doi: 10.2196/47430. J Med Internet Res. 2024. PMID: 38241075 Free PMC article.
-
Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).Diabetes. 2019 Feb;68(2):409-419. doi: 10.2337/db18-0515. Epub 2018 Nov 8. Diabetes. 2019. PMID: 30409781 Free PMC article.
-
Hyperlipidemia and Cardiovascular Disease in People with Type 1 Diabetes: Review of Current Guidelines and Evidence.Curr Cardiol Rep. 2023 May;25(5):435-442. doi: 10.1007/s11886-023-01866-x. Epub 2023 Apr 13. Curr Cardiol Rep. 2023. PMID: 37052761 Review.
-
Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control.Curr Cardiol Rep. 2022 Oct;24(10):1467-1475. doi: 10.1007/s11886-022-01763-9. Epub 2022 Aug 10. Curr Cardiol Rep. 2022. PMID: 35947333 Review.
-
Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.Diabetes Res Clin Pract. 2020 May;163:108141. doi: 10.1016/j.diabres.2020.108141. Epub 2020 Apr 8. Diabetes Res Clin Pract. 2020. PMID: 32277955 Free PMC article.
References
-
- Orchard TJ, Costacou T. When are type 1 diabetic patients at risk for cardiovascular disease? Curr Diab Rep. 2010 Mar;10(1):48–54. - PubMed
-
- Lloyd CE, Kuller LH, Ellis D, et al. Coronary Artery Disease in IDDM: Gender differences in risk factors, but not risk. Arterioscler Thromb Vasc Biol. 1996;16(6):720–26. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical